首頁 > 市場調查報告書 > 食物/飲料

食品添加劑

市場調查報告書

商品編碼

1423950

解毒劑市場、份額、規模、趨勢、行業分析報告：按類型、給藥途徑、分銷管道、最終用途、地區、細分市場預測，2024-2032

Antidote Market Share, Size, Trends, Industry Analysis Report, By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route of Administration, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2024- 2032

出版日期: 2024年01月24日 | 出版商:

Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據Polaris Market Research的最新研究，預計到2032年，全球解毒劑市場規模將達到40.5236億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

市場主要受到蛇咬傷流行及其相關負面影響的推動。例如，2023 年 PLOS 發表的一篇研究論文報告稱，印度約有 58,000 人因蛇咬傷死亡。此外，藥物過量的增加是市場的主要驅動因素。根據美國衛生與公眾服務部的數據，2021 年美國約有 106,699 人因藥物過量死亡。解毒劑透過中和某些藥物來發揮作用。例如，納洛酮通常用於逆轉阿片類藥物過量期間的呼吸抑制。解毒劑的這些特點有助於市場的成長。

此外，職業中毒發生率的上升也是解毒劑需求增加的重要原因。阿片類藥物過量、氫氰酸中毒、一氧化碳中毒、鉛中毒、有機磷中毒等發生率的增加擴大了解毒劑的使用。例如，根據 NCBI 2020 年 12 月的研究論文，全球約有 3.85 億起農藥意外中毒病例，導致 11,000 人死亡。因此，預計市場在預測期內將快速成長。

此外，一系列旨在教育大眾進行毒素識別的意識舉措，加上政府努力提高解毒劑和藥物知識，預計將推動整體市場成長。另一方面，正在進行的研究和開發的重點是提高有毒物質在中毒和接觸有毒物質管理中的可用性、有效性和安全性，並將在不久的將來將其推向市場。這似乎提供了有利可圖的機會機會。

然而，由於製造限制和監管障礙，解毒劑的供應有限，可能會阻礙獲得救生解毒劑。某些解毒劑的高成本可能是一個經濟障礙。此外，儲存條件、保質期、知識和訓練需求可能會限制解毒劑的應用。

解毒劑市場報告要點

化學解毒劑所佔比重最大。

由於住院病患數量、重症監護設施和訓練有素的醫療專業人員數量不斷增加，醫院主導市場

由於鴉片類藥物危機、成癮病例不斷增加以及參與研發的大公司的存在，北美佔據了最大的份額。

主要市場參與者包括輝瑞、Hikma Pharmaceuticals、Mylan、Fresenius、Zydus Lifesciences、Endo International、Baxter 和 Emergent Biosolutions。

主要發現
簡介
- 2019-2032 年按地區劃分的解毒劑市場評估
解毒劑市場－北美
- 北美：解毒劑市場，依給藥途徑，2019-2032 年
- 北美：解毒劑市場，依通路劃分，2019-2032 年
- 北美：解毒劑市場，按類型，2019-2032 年
- 解毒劑市場－美國
- 解毒劑市場 - 加拿大
解毒劑市場 - 歐洲
- 歐洲：解毒劑市場（依給藥途徑），2019-2032 年
- 歐洲：解毒劑市場，依通路劃分，2019-2032 年
- 歐洲：解毒劑市場，依類型，2019-2032 年
- 解毒劑市場 - 英國
- 解毒劑市場－法國
- 解毒劑市場－德國
- 解毒劑市場 - 義大利
- 解毒劑市場 - 西班牙
- 解毒劑市場 - 荷蘭
- 解毒劑市場 - 俄羅斯
解毒劑市場 - 亞太地區
- 亞太地區：解毒劑市場（依給藥途徑），2019-2032 年
- 亞太地區：解毒劑市場，依通路劃分，2019-2032 年
- 亞太地區：2019-2032 年解毒劑市場（按類型）
- 解毒劑市場 - 中國
- 解毒劑市場 - 印度
- 解毒劑市場 - 馬來西亞
- 解毒劑市場 - 日本
- 解毒劑市場 - 印度尼西亞
- 解毒劑市場 - 韓國
解毒劑市場 - 中東和非洲
- 中東和非洲：解毒劑市場（按給藥途徑），2019-2032 年
- 中東與非洲：解毒劑市場，依通路劃分，2019-2032 年
- 中東和非洲：解毒劑市場，按類型，2019-2032 年
- 解毒劑市場－沙烏地阿拉伯
- 解毒劑市場－阿拉伯聯合大公國
- 解毒劑市場 - 以色列
- 解毒劑市場 - 南非
解毒劑市場 - 拉丁美洲
- 拉丁美洲：解毒劑市場，依給藥途徑劃分，2019-2032 年
- 拉丁美洲：解毒劑市場，依通路劃分，2019-2032 年
- 拉丁美洲：解毒劑市場，按類型，2019-2032 年
- 解毒劑市場 - 墨西哥
- 解毒劑市場 - 巴西
- 解毒劑市場 - 阿根廷

第9章競爭態勢

擴張與收購分析
- 放大
- 收購
夥伴關係/協作/協議/揭露

第10章公司簡介

Pfizer Inc.
Hikma Pharmaceuticals PLC
Dr. Reddy's Laboratories Ltd
Mylan N.V.
Fresenius Kabi AG
Zydus Lifesciences Ltd.
Endo International plc
Novartis AG
Baxter International, Inc.
Emergent BioSolutions Inc

簡介目錄圖表

Product Code: PM4182

The global antidote market size is expected to reach USD 4,052.36 Million by 2032, according to a new study by Polaris Market Research. The report "Antidote Market Share, Size, Trends, Industry Analysis Report, By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route of Administration, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is predominantly propelled by the prevalence of snakebites and the associated adverse effects. For instance, a research article published in PLOS in 2023 reported approximately 58,000 deaths in India attributed to snake bites. Additionally, the increase in the number of drug overdoses is a key driver for the market. According to the U.S. Department of Health & Human Services, around 106,699 drug overdose deaths were recorded in the U.S. in 2021. Antidotes work to neutralize specific drugs. For instance, Naloxone is commonly used to reverse respiratory depression in opioid overdoses. These capabilities of antidotes contribute to the growth of the market.

Moreover, the escalating prevalence of occupational poisoning is playing a significant role in the heightened demand for antidotes. The applications of antidotes are expanding due to the increasing incidence of conditions such as opioid overdose, cyanide and CO poisoning, lead poisoning, and organo-phosphate poisoning, among others. For instance, according to a research article by NCBI in December 2020, there were approximately 385 million instances of unintentional pesticide poisoning worldwide, resulting in 11,000 deaths. Consequently, the market is anticipated to experience rapid growth during the forecast period.

Moreover, a series of awareness initiatives aimed at educating the public on toxin identification, coupled with government efforts to enhance knowledge of antidotes and drugs, is expected to propel the overall market growth. On the flip side, ongoing research and development endeavors are focused on improving availability, effectiveness, and safety in managing poisonings and toxic exposures, presenting lucrative opportunities for the market soon.

However, the limited availability of antidotes due to the manufacturing constraints and regulatory hurdles may impede access to the life-saving antidotes. The high costs associated with certain antidotes could create financial barriers. Additionally, storage requirements, shelf-life, and the need for knowledge and training may constrain the applications of antidotes.

Antidote Market Report Highlights

Chemical antidote held the largest share, due to minimized compilations, consistent outcomes, and precise dosing

Hospitals dominated the market, owing to increasing number of hospitalizations, batter facilities, and trained medical professionals

North America accounted for the largest share, due to rise in opioid crisis, poisoning cases, and presence of key companies involved in R&D

The key market players include Pfizer, Hikma Pharmaceuticals, Mylan, Fresenius, Zydus Lifesciences, Endo International, Baxter, & Emergent BioSolutions.

Polaris Market Research has segmented the antidote market report based on type, route of administration, distribution channel, end use, and region:

Antidote, Type Outlook (Revenue - USD Million, 2023 - 2032)

Chemical Antidote
Physical Antidote
Pharmacological Antidote

Antidote, Route of Administration Outlook (Revenue - USD Million, 2023 - 2032)

Oral
Topical
Injectable
Others

Antidote, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Antidote, End Use Outlook (Revenue - USD Million, 2023 - 2032)

Hospital
Homecare
Specialty Clinics
Others

Antidote, Regional Outlook (Revenue - USD Million, 2023 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Antidote Market Insights

4.1. Antidote Market - Distribution Channel Snapshot
4.2. Antidote Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Incidence of Poisonings
  - 4.2.1.2. Growing Drug Abuse
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Antidote Market Distribution Channel Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Antidote Market, by Route of Administration

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Antidote Market, by Route of Administration, 2019-2032 (USD Million)
5.3. Oral
- 5.3.1. Global Antidote Market, by Oral, by Region, 2019-2032 (USD Million)
5.4. Topical
- 5.4.1. Global Antidote Market, by Topical, by Region, 2019-2032 (USD Million)
5.5. Injectable
- 5.5.1. Global Antidote Market, by Injectable, by Region, 2019-2032 (USD Million)
5.6. Others
- 5.6.1. Global Antidote Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Antidote Market, by Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Antidote Market, by Type, 2019-2032 (USD Million)
6.3. Chemical Antidote
- 6.3.1. Global Antidote Market, by Chemical Antidote, by Region, 2019-2032 (USD Million)
6.4. Physical Antidote
- 6.4.1. Global Antidote Market, by Physical Antidote, by Region, 2019-2032 (USD Million)
6.5. Pharmacological Antidote
- 6.5.1. Global Antidote Market, by Pharmacological Antidote, by Region, 2019-2032 (USD Million)

7. Global Antidote Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
7.3. Hospital Pharmacies
- 7.3.1. Global Antidote Market, by Hospital Pharmacies, By Region, 2019-2032 (USD Million)
7.4. Retail Pharmacies
- 7.4.1. Global Antidote Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
7.5. Online Pharmacies
- 7.5.1. Global Antidote Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Antidote Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
8.3. Antidote Market - North America
- 8.3.1. North America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
- 8.3.2. North America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.3. North America: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.3.4. Antidote Market - U.S.
  - 8.3.4.1. U.S.: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.3.4.2. U.S.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.3.4.3. U.S.: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.3.5. Antidote Market - Canada
  - 8.3.5.1. Canada: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.3.5.2. Canada.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.3.5.3. Canada: Antidote Market, by Type, 2019-2032 (USD Million)
8.4. Antidote Market - Europe
- 8.4.1. Europe: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
- 8.4.2. Europe.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.3. Europe: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.4.4. Antidote Market - UK
  - 8.4.4.1. UK: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.4.4.2. UK.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.4.4.3. UK: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.4.5. Antidote Market - France
  - 8.4.5.1. France: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.4.5.2. France.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.4.5.3. France: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.4.6. Antidote Market - Germany
  - 8.4.6.1. Germany: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.4.6.2. Germany.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.4.6.3. Germany: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.4.7. Antidote Market - Italy
  - 8.4.7.1. Italy: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.4.7.2. Italy.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.4.7.3. Italy: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.4.8. Antidote Market - Spain
  - 8.4.8.1. Spain: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.4.8.2. Spain.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.4.8.3. Spain: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.4.9. Antidote Market - Netherlands
  - 8.4.9.1. Netherlands: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.4.9.2. Netherlands.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.4.9.3. Netherlands: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.4.10. Antidote Market - Russia
  - 8.4.10.1. Russia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.4.10.2. Russia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.4.10.3. Russia: Antidote Market, by Type, 2019-2032 (USD Million)
8.5. Antidote Market - Asia Pacific
- 8.5.1. Asia Pacific: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.5.4. Antidote Market - China
  - 8.5.4.1. China: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.5.4.2. China.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.5.4.3. China: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.5.5. Antidote Market - India
  - 8.5.5.1. India: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.5.5.2. India.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.5.5.3. India: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.5.6. Antidote Market - Malaysia
  - 8.5.6.1. Malaysia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.5.6.2. Malaysia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.5.6.3. Malaysia: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.5.7. Antidote Market - Japan
  - 8.5.7.1. Japan: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.5.7.2. Japan.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.5.7.3. Japan: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.5.8. Antidote Market - Indonesia
  - 8.5.8.1. Indonesia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.5.8.2. Indonesia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.5.8.3. Indonesia: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.5.9. Antidote Market - South Korea
  - 8.5.9.1. South Korea: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.5.9.2. South Korea.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.5.9.3. South Korea: Antidote Market, by Type, 2019-2032 (USD Million)
8.6. Antidote Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.6.4. Antidote Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.6.4.2. Saudi Arabia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.6.4.3. Saudi Arabia: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.6.5. Antidote Market - UAE
  - 8.6.5.1. UAE: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.6.5.2. UAE.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.6.5.3. UAE: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.6.6. Antidote Market - Israel
  - 8.6.6.1. Israel: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.6.6.2. Israel.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.6.6.3. Israel: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.6.7. Antidote Market - South Africa
  - 8.6.7.1. South Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.6.7.2. South Africa.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.6.7.3. South Africa: Antidote Market, by Type, 2019-2032 (USD Million)
8.7. Antidote Market - Latin America
- 8.7.1. Latin America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.3. Latin America: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.7.4. Antidote Market - Mexico
  - 8.7.4.1. Mexico: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.7.4.2. Mexico.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.7.4.3. Mexico: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.7.5. Antidote Market - Brazil
  - 8.7.5.1. Brazil: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.7.5.2. Brazil.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.7.5.3. Brazil: Antidote Market, by Type, 2019-2032 (USD Million)
- 8.7.6. Antidote Market - Argentina
  - 8.7.6.1. Argentina: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  - 8.7.6.2. Argentina.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  - 8.7.6.3. Argentina: Antidote Market, by Type, 2019-2032 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Pfizer Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Hikma Pharmaceuticals PLC
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Dr. Reddy's Laboratories Ltd
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Mylan N.V.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Fresenius Kabi AG
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Zydus Lifesciences Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Endo International plc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Novartis AG
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Baxter International, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Emergent BioSolutions Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 2 Global Antidote Market, by Type, 2019-2032 (USD Million)
Table 3 Global Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 4 Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
Table 5 North America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 6 North America: Antidote Market, by Type, 2019-2032 (USD Million)
Table 7 North America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 8 U.S.: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 9 U.S.: Antidote Market, by Type, 2019-2032 (USD Million)
Table 10 U.S.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 11 Canada: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 12 Canada: Antidote Market, by Type, 2019-2032 (USD Million)
Table 13 Canada: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 14 Europe: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 15 Europe: Antidote Market, by Type, 2019-2032 (USD Million)
Table 16 Europe: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 17 UK: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 18 UK: Antidote Market, by Type, 2019-2032 (USD Million)
Table 19 UK: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 20 France: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 21 France: Antidote Market, by Type, 2019-2032 (USD Million)
Table 22 France: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 23 Germany: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 24 Germany: Antidote Market, by Type, 2019-2032 (USD Million)
Table 25 Germany: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 26 Italy: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 27 Italy: Antidote Market, by Type, 2019-2032 (USD Million)
Table 28 Italy: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 29 Spain: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 30 Spain: Antidote Market, by Type, 2019-2032 (USD Million)
Table 31 Spain: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 32 Netherlands: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 33 Netherlands: Antidote Market, by Type, 2019-2032 (USD Million)
Table 34 Netherlands: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 35 Russia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 36 Russia: Antidote Market, by Type, 2019-2032 (USD Million)
Table 37 Russia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 38 Asia Pacific: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 39 Asia Pacific: Antidote Market, by Type, 2019-2032 (USD Million)
Table 40 Asia Pacific: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 41 China: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 42 China: Antidote Market, by Type, 2019-2032 (USD Million)
Table 43 China: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 44 India: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 45 India: Antidote Market, by Type, 2019-2032 (USD Million)
Table 46 India: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 47 Malaysia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 48 Malaysia: Antidote Market, by Type, 2019-2032 (USD Million)
Table 49 Malaysia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 50 Japan: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 51 Japan: Antidote Market, by Type, 2019-2032 (USD Million)
Table 52 Japan: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 53 Indonesia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 54 Indonesia: Antidote Market, by Type, 2019-2032 (USD Million)
Table 55 Indonesia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 56 South Korea: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 57 South Korea: Antidote Market, by Type, 2019-2032 (USD Million)
Table 58 South Korea: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 59 Middle East & Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 60 Middle East & Africa: Antidote Market, by Type, 2019-2032 (USD Million)
Table 61 Middle East & Africa: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 62 Saudi Arabia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 63 Saudi Arabia: Antidote Market, by Type, 2019-2032 (USD Million)
Table 64 Saudi Arabia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 65 UAE: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 66 UAE: Antidote Market, by Type, 2019-2032 (USD Million)
Table 67 UAE: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 68 Israel: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 69 Israel: Antidote Market, by Type, 2019-2032 (USD Million)
Table 70 Israel: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 71 South Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 72 South Africa: Antidote Market, by Type, 2019-2032 (USD Million)
Table 73 South Africa: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 74 Latin America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 75 Latin America: Antidote Market, by Type, 2019-2032 (USD Million)
Table 76 Latin America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 77 Mexico: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 78 Mexico: Antidote Market, by Type, 2019-2032 (USD Million)
Table 79 Mexico: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 80 Brazil: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 81 Brazil: Antidote Market, by Type, 2019-2032 (USD Million)
Table 82 Brazil: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
Table 83 Argentina: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
Table 84 Argentina: Antidote Market, by Type, 2019-2032 (USD Million)
Table 85 Argentina: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Antidote Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type
Figure 7. Global Antidote Market, by Type, 2022 & 2032 (USD Million)
Figure 8. Market by Route of Administration
Figure 9. Global Antidote Market, by Route of Administration, 2022 & 2032 (USD Million)
Figure 10. Market by Distribution Channel
Figure 11. Global Antidote Market, by Distribution Channel, 2022 & 2032 (USD Million)
Figure 12. Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 13. Strategic Analysis - Antidote Market